A New World of Cancer Therapy

Developing next-generation targeted combination therapies to advance the care of cancer patients.

White alpha letter on transparent background
White beta letter on transparent background

A New World of Cancer Therapy.

Developing next-generation targeted combination therapies to advance the care of cancer patients

Convergent Therapeutics, Inc. is a biotechnology company focused on developing next-generation targeted combination therapies to treat cancer.

Company

Connect

Contact

info@convergentrx.com

Congratulations to Dr. Scott Tagawa at Weill Cornell Medicine for his recent poster presentation at the American Association for Cancer research (#AACR) Annual Meeting on the first in human radioligand/radioantibody clinical trial for advanced prostatecancer.

Read More
X